The bill mandates the Secretary of Veterans Affairs to review regulations and establish a clear definition of "peptide." A study will then evaluate the safety and therapeutic benefits of peptide-based therapies for veterans at VA medical facilities. If deemed beneficial, a pilot program will be conducted to assess the effectiveness of peptide treatments. The report will include findings, recommendations, and a determination on whether peptide-based therapies should be provided to veterans. A follow-up report will detail the effectiveness of peptide treatments, provide guidance for large-scale implementation, and address challenges encountered in the pilot program.